Modern life sciences is outgrowing legacy networks

May 21, 2026 | 2 minute read

Modern life sciences is outgrowing legacy networks

Every delay now has scientific, operational, and commercial consequences

Life sciences network infrastructure is under pressure to support more across every stage of the business. And to support speed.

Faster trials. Faster research. Faster manufacturing decisions. Faster AI adoption.

But speed creates a new dependency: uninterrupted access to data, systems, and cloud environments across the entire organization.

A slow network no longer feels like an IT problem.

It feels like delayed trial timelines. Slower collaboration between global research teams. Manufacturing risk. AI models waiting on data they cannot reach fast enough.

Discover why more life sciences IT leaders are prioritizing resilience, visibility, and predictable global performance in their network strategies.

Life sciences internet network challenges infographic

What you’ll learn in this infographic

Modern infrastructure demands more than connectivity. It demands operational consistency.

Globe with orbiting circles
  1. New providers added regionally
  2. Cloud environments layered onto legacy infrastructure
  3. Connectivity decisions made site by site
  4. Visibility fragmented across platforms and vendors
Shield with globe
Why forward-thinking businesses are investing in network resilience for:
  • Predictable global performance
  • Built-in resilience across sites and regions
  • Centralized operational visibility
  • Faster issue identification and resolution
  • Simplified accountability across providers

Share to

Stay connected with Expereo

Be the first to hear about our latest insights, news, and updates.